Opus Genetics (IRD) Cash & Equivalents Growth (1y) (2011 - 2026)
Opus Genetics (IRD) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
988.88% |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-68.22% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
0.00% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
4.77% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
3.35% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
269.98% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
17.50% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Opus Genetics |
350.17 Mn |
290.21 Mn |
- |
43.44% |
| Date | Value |
|---|
| Mar 31, 2026 |
43.44% |
| Dec 31, 2025 |
48.71% |
| Sep 30, 2025 |
-15.85% |
| Jun 30, 2025 |
-21.69% |
| Mar 31, 2025 |
-11.37% |
| Dec 31, 2024 |
-39.96% |
| Sep 30, 2024 |
-13.68% |
| Jun 30, 2024 |
3.52% |
| Mar 31, 2024 |
20.96% |
| Dec 31, 2023 |
18.45% |
| Sep 30, 2023 |
206.03% |
| Jun 30, 2023 |
134.95% |
| Mar 31, 2023 |
102.58% |
| Dec 31, 2022 |
73.78% |
| Sep 30, 2022 |
-37.73% |
| Jun 30, 2022 |
-29.75% |
| Mar 31, 2022 |
81.62% |
| Dec 31, 2021 |
49.61% |
| Sep 30, 2021 |
175.39% |
| Jun 30, 2021 |
163.16% |
